Armata Pharmaceuticals, Inc. Common Stock (ARMP) is a publicly traded Healthcare sector company. As of May 21, 2026, ARMP trades at $8.18 with a market cap of $279.00M and a P/E ratio of -1.71. ARMP moved -3.78% today. Year to date, ARMP is +27.87%; over the trailing twelve months it is +260.89%. Its 52-week range spans $0.90 to $16.34. Analyst consensus is buy with an average price target of $17.50. Rallies surfaces ARMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own ARMP include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Armata Pharmaceuticals, Inc. Common Stock.
| Metric | Value |
|---|---|
| Price | $8.18 |
| Market Cap | $279.00M |
| P/E Ratio | -1.71 |
| EPS | $-4.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.34 |
| 52-Week Low | $0.90 |
| Volume | 210 |
| Avg Volume | 0 |
| Revenue (TTM) | $4.90M |
| Net Income | $-173.80M |
| Gross Margin | 0.00% |
2 analysts cover ARMP: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $17.50.